Concepedia

A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites

Nicoletta Colombo, Giorgia Mangili, Serafina Mammoliti, M. Kalling, Bengt Tholander, Lars Sternås, Giliane Buzenet, Donald H. Chamberlain

Gynecologic Oncology · 2011 · 94 citations · 20 references

DOI

Concepts

References

20

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

VEGF-Trap: A VEGF blocker with potent antitumor effects

Jocelyn Holash, Sam Davis, Susan D. Croll et al. · Proceedings of the National Academy of Sciences · 2002 · 1.7K citations

, , +17

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

Andrea Kraft, Karin Weindel, Andreas Ochs et al. · Cancer · 1999 · 370 citations

, , +9

Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.

Annette T. Byrne, Leorah Ross, Joceyln Holash et al. · PubMed · 2003 · 312 citations

, , +17

Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites

Brian K. Zebrowski, W Liu, Karen Ramirez et al. · Annals of Surgical Oncology · 1999 · 259 citations

, , +15